Koch Kevin's Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Feb 7, 2025
- Accession no.
- 0001562180-25-001025
- Filed
- Feb 7, 2025, 4:38 PM ET
- Trade date
- Feb 5-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $287.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Koch KevinCIK 0001185829 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | Common Stock | MOption exerciseAcquired | +8,636 | $0.18 | +$1,554.48 | 23,114 | Direct | |
| Feb 5, 2025 | Common Stock | SSaleDisposed | −8,636 | $30.03 | −$259,297.63 | 14,478 | Direct | |
| Feb 6, 2025 | Common Stock | MOption exerciseAcquired | +900 | $13.11 | +$11,799 | 15,378 | Direct | |
| Feb 6, 2025 | Common Stock | SSaleDisposed | −900 | $31.13 | −$28,017.99 | 14,478 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | Common Stock | MOption exerciseDisposed | −8,636 | $0.00 | $0 | 42,545 | Direct | |
| Feb 6, 2025 | Common Stock | MOption exerciseDisposed | −900 | $0.00 | $0 | 41,645 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.